Thought Leaders for Health Care Marketers

DTC Perspectives is the chief source of best practices, knowledge, and insight for leading healthcare marketers creating and implementing direct-to-consumer communications

What We Do


https://www.dtcperspectives.com/wp-content/uploads/2022/07/Conference-Presentation-shutterstock_1933586570square.jpg

Learn More


Live

Events

Join and network with healthcare marketing leaders in-person at our live events, over 20 years running.

https://www.dtcperspectives.com/wp-content/uploads/2022/07/Talking-DTC-Talking-Health-Sponsor-Advertise-BannerSquare-Shadowed.jpg

Learn More


Talking DTC

Webinars

Tune in live or view past recordings of Talking Health to hear industry experts discuss the future of health marketing

https://www.dtcperspectives.com/wp-content/uploads/2022/07/award-shutterstock_1788126140-shadow.jpg

Learn More


Industry

Awards

Honoring the health marketing industry’s best campaigns and individuals. Submit your best work and nominate excellent individuals today!

Our Audience



Sponsor DTC National Conference

SPONSOR

Advertise with DTC Perspectives

ADVERTISE

News

https://www.dtcperspectives.com/wp-content/uploads/2024/12/Direct-Consumer-Pharma-Drug-Sales-320x240.jpg
December 3, 2024

One of the current trends in DTC marketing is the availability of some branded drugs shipped directly from the manufacturer. Some pharmaceutical companies are starting to cut the wholesalers and retailers out of the purchase cycle. While still in its infancy, the direct to consumer operations have enormous implications for how consumers will get their […]

https://www.dtcperspectives.com/wp-content/uploads/2024/11/RFK-Gavel-Capitol-DALLE-320x240.jpeg
November 19, 2024

Explore the potential impact of Robert Kennedy Jr.’s nomination to head HHS on the future of direct-to-consumer (DTC) pharmaceutical advertising. Understand the legal and regulatory challenges that could reshape the industry.

https://www.dtcperspectives.com/wp-content/uploads/2024/11/Trump-2024-election-shutterstock_2541616777-320x240.jpg
November 12, 2024

The election of Donald Trump is having pharmaceutical companies evaluate how things may change in terms of legislation and regulation. Trump is not yet clear on his moves regarding pharma. In his first term, he criticized the drug companies for pricing higher in the U.S. than other developed countries. Republicans in Congress have generally not […]

https://www.dtcperspectives.com/wp-content/uploads/2024/11/GLP1-injector-pen-shutterstock-320x240.jpg
November 6, 2024

On September 24, Novo Nordisk CEO Lars Jørgensen testified before the Senate which I watched on C-SPAN. He was asked to appear to discuss the reasons for high prices for GLP-1 diabetes drug Ozempic and its weight loss sister drug Wegovy. The savaging of drug company pricing policies is an ongoing cause for Sen. Sanders. […]

More news…